SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and social media users closely monitor the company's ticker alongside volatile geopolitical developments in the Middle East. The community is actively debating the potential economic and political consequences of the current administration's foreign policy maneuvers, with discourse heavily polarized between strong institutional support and harsh criticism regarding the potential for wider conflict and regional instability.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is capturing investor interest as a potential acquisition target in the high-stakes obesity market, driven by clinical progress for its muscle-sparing WVE-007 candidate and regained full rights to its AATD therapy, WVE-006. The community is actively discussing the stock's long-term potential as a differentiated RNA-based alternative to traditional GLP-1 treatments, with analysts highlighting these upcoming readouts as key catalysts for a significant valuation rerating.

Superfluid is a revolutionary asset streaming and distribution protocol bringing subscriptions, salaries, vesting, and rewards to DAOs and crypto-native businesses worldwide. This is made possible by the protocol’s smart contract framework which introduces the Super Token - an extension to the ERC-20 standard enabling the transfer of value in completely novel ways.

Superfluid

Superfluid is gaining attention due to its highly decentralized holder structure and rumors of imminent listings on additional exchanges beyond its current exclusive Coinbase presence. Investors are actively debating the token's long-term potential as part of broader ecosystem momentum, though sentiment remains highly polarized between those eyeing rapid growth and others expressing caution over recent volatility.

$RARI is an ERC-20 token that controls the RARI Foundation treasury and governs the Rarible protocol and RARI Chain. The token was issued in 2020 with a max. supply of 25 million $RARI.

Rarible

Rarible is generating significant buzz due to its ultra-low circulating supply, leading the community to discuss its potential for rapid price appreciation and a possible supply shock. Many investors are actively accumulating the token, betting that increased volume will trigger a major breakout for the NFT-focused platform.

Derive is a decentralized protocol that creates programmable onchain options, perpetuals, and structured products.   Derive is deployed and operates on Derive Chain, an Ethereum rollup built using the OP stack and is the home of the Derive Protocol. It is a permission-less smart contract platform.  The Derive DAO earns trading fees from the Derive Protocol and gas fees from the Derive Chain, governed by DRV token holders. Trading fees accrue to an insurance fund to foster robustness of the protocol and rollup.  Derive has built an AI-powered trading app built for pro traders. In collaboration with Messari, Derive Pro translates market views into trades. The agent then prepares transactions for users and leverages smart contract wallets to make trades one-click, gasless and chainless. The app will support spot, perps and options trading on Derive, and will also plug in to spot AMMs on L2s like Optimism, Arbitrum and Base.

Derive

Derive is gaining significant momentum and community attention as investors highlight its ongoing consolidation, recent protocol developments like the Onchain Matrix, and anticipation surrounding upcoming buybacks. Traders are actively discussing the token's technical strength and its strategic partnership with Synthetix, fueling a narrative of long-term growth potential.

Pelican Acquisition Corporation is a special-purpose acquisition company that aims to merge with or acquire businesses, particularly in the global technology sector. The company's primary purpose of facilitate a merger, share exchange, asset acquisition, share purchase, reorganization, or any other form of business combination with one or more businesses.

Greenland Energy Co.

Greenland Energy Co. (GLND) is trending as retail investors speculate on a massive potential oil discovery in the Jameson Land Basin, with community discussions heavily focused on the company's drilling contracts and speculative future price targets. While some bulls are citing long-term energy security and institutional involvement as catalysts for a major surge, skeptics are actively warning about the stock's volatility, potential dilution, and the high-risk nature of speculative Arctic exploration.

Tema ETF Trust - Tema Space Innovators ETF

The newly launched Tema Space Innovators ETF (NASA) is generating significant buzz as investors seek exposure to the space economy, particularly through its allocated stake in SpaceX. Community members are actively debating the fund's potential as a long-term play versus a volatile trading vehicle, with many comparing it to other space-themed tickers as excitement builds ahead of the highly anticipated SpaceX IPO.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending as investors digest the recent analyst upgrades and institutional accumulation following the company's Japan marketing approval. The community is actively discussing the stock's resilience against market volatility, focusing on the upcoming Phase 3 trial milestones and the firm's strong cash position as key catalysts for future growth.

VS Trust - 2x Long VIX Futures ETF

Volatility Shares 2x Long VIX Futures ETF

UVIX is experiencing intense volatility as investors weigh conflicting reports of peace negotiations against persistent concerns over escalating Middle East conflicts and potential disruptions to global oil supplies. The community is actively debating the reliability of diplomatic announcements versus the reality of ongoing regional tensions, leading to a polarized environment where traders are using the ETF as a high-stakes hedge against potential market corrections.

Global X Funds - Global X DAX Germany ETF

Global X DAX Germany ETF

The Global X DAX Germany ETF is currently a focal point for traders using Elliott Wave analysis, as the index shows technical signals for a potential rally resumption following a period of volatility and consolidation. Community discussions are heavily centered on identifying high-probability support zones and structural trend reversals, with many weighing the impact of broader geopolitical tensions and energy dynamics on German industrial performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Current Price	$28.69
Prev Close	$27.70
Open	$28.31
Dividend Yield	1.92%
50-Day Moving Average	$29.51
Beta	0.40
Avg. Volume	1,397.45
PE Ratio	3.01

52-Week High	$31.80
52-Week Low	$20.08
Market Capitalization	$35.31B
EPS (Annual)	$9.47
Price to Book	1.13
Revenue Per Employee	$2.42M

GILD.TSX
Gilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GILD.TSX News

GILD.TSXGilead Sciences, Inc. - Gilead Sciences CDR (CAD Hedged) - CIBC